首页> 外国专利> Antihypertensive 5-benzyl-1,2,4-oxadiazole derivs. - with negligible sedative activity, for treatment of essential or secondary hypertension

Antihypertensive 5-benzyl-1,2,4-oxadiazole derivs. - with negligible sedative activity, for treatment of essential or secondary hypertension

机译:降压的5-苄基-1,2,4-恶二唑衍生物。 -镇静作用微不足道,用于治疗原发性或继发性高血压

摘要

Oxadiazole derivs. of formula (I) and their pharmaceutically acceptable acid addn. salts are new (where R1-5 are each H, halogen, or alkyl, or 2 adjacent gps. together with the benzene nucleus may form a naphthalene system, and 2 of R1-5 are not H when R is NH2; R is -NR'R" or -N=CR'3-NR'1R'2; R' is H, dialkylaminoalkyl, hydroxyalkyl, dialkylamino-alkoxycarbonyl, pyridinoalkyl or alkyl; R" is H or alkyl; R'3 is H, alkyl, aryl or aralkyl; R'1 and R'2 are each alkyl, hydroxyalkyl or dialkylamino-alkyl; or -NR'R" or -NR'1R'2 may form a heterocycle opt contg. another heteroatom which may be substd. by alkyl; all alkyl gps. are 1-4C). (I) are antihypertensives, useful in treatment of essential or secondary hypertension, and have negligible sedative activity. Doses are e.g. 4-100 mg p.o/day.
机译:恶二唑衍生。式(I)的化合物及其药学上可接受的酸附加物。盐是新的盐(其中R1-5分别为H,卤素或烷基,或2个相邻的gps。可能与苯核一起形成萘系统,并且当R为NH2时,R1-5的2个不是H; R为- NR'R“或-N = CR'3-NR'1R'2; R'为H,二烷基氨基烷基,羟烷基,二烷基氨基-烷氧基羰基,吡啶基烷基或烷基; R”为H或烷基; R'3为H,烷基,芳基或芳烷基; R'1和R'2各自为烷基,羟烷基或二烷基氨基-烷基;或-NR'R“或-NR'1R'2可形成一个杂环,与另一个杂原子取代,该杂原子可被烷基取代;所有烷基的gps。均为1-4C)(I)是抗高血压药,可用于治疗原发性或继发性高血压,并且镇静作用可忽略不计,剂量为4-100 mg po / day。

著录项

  • 公开/公告号FR2397408B1

    专利类型

  • 公开/公告日1980-04-04

    原文格式PDF

  • 申请/专利权人 SYNTHELABO;

    申请/专利号FR19770021447

  • 发明设计人

    申请日1977-07-12

  • 分类号C07D271/06;A61K31/41;

  • 国家 FR

  • 入库时间 2022-08-22 17:23:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号